In this Bioanalysis Zone interview, Stephane Moreau (Shimadzu Europa; Duisburg, Germany) discusses the benefits of the new Q-TOF LCMS-9030 instrument developed by Shimadzu including improved stability, robustness and less frequent calibration requirements. Stephane also introduces the MSW tool for microsampling and the nSMOL monoclonal antibody kit, before predicting what the field of automation and instrumentation may look like in 5–10 years’ time.
If you enjoyed this interview, you might also like…
Microsampling in sports drug testing – an interview with Laura Mercolini (University of Bologna)
An interview with Stephane Moreau (Shimadzu) discussing nSMOL monoclonal antibody analysis
Application of Mitra® Microsampling for Pharmacokinetic Bioanalysis of Monoclonal Antibodies in Rats